Autres langues

03/01/17 Serodus : Primary endpoint reached by SER150 Phase 2a study in Diabetic Nephropathy.
08/12/16 Serodus : Q&A delisting from Oslo Axess
23/11/16 Serodus : Extraordinary general meeting held
23/11/16 Serodus : Viggo Harboe Holding 2006 ApS announces results of voluntary offer
02/11/16 Serodus : Viggo Harboe Holding 2006 Aps Launces voluntary offer for outstanding shares in Serodus ASA – Acceptance period starting 31 October 2016
27/10/16 Serodus : Q3 2016 Interim results
22/10/16 Serodus : DISCLOSURE OF HOLDINGS AND MANDATORY NOTIFICATION OF TRADE PRIMARY INSIDERS New article
22/10/16 Serodus : Evaluating financing model – prolonging timeline
22/10/16 Serodus : Invitation for shareholders meeting
22/10/16 Serodus : Evaluating financing model
20/08/16 Serodus : Q2-2016 Interim Results
30/06/16 Serodus ASA : MANDATORY NOTIFICATION OF TRADE PRIMARY INSIDERS
25/04/16 Serodus ASA : Invitation to a presentation of Serodus in Copenhagen
07/04/16 Serodus ASA : to evaluate financing options for lead programs
17/02/16 Serodus ASA : Q4-2015 Interim results
12/02/16 Serodus ASA : Invitation to a presentation of Q4 2015 results
19/01/16 Serodus ASA : We are delighted to announce that Anthony Rosenberg has joined SERODUS ASA as an advisor
12/01/16 Serodus ASA : Results of Serodus’ SER140 in diabetic mice will be published in the Journal of Diabetic Research
17/12/15 Serodus ASA : at the 34th J.P. Morgan Healthcare Conference
17/12/15 SERODUS ASA : appoints scientific advisors for development program in Acute Myocardial Infarction (SER130)
03/11/15 SERODUS ASA : to present at the BIO Europe 2015 in Munich November 2-4
27/10/15 Serodus ASA : Q3-2015 Interims results
17/08/15 Serodus ASA : Extraordinary general meeting held – The proposed rights issue was resolved – Last day of trading inclusive the right to participate in the rights issue
14/08/15 Serodus ASA : Q2-2015 results
24/07/15 Serodus ASA : Notice of Extraordinary General Meeting 17 August 2015
Aucun résultat pour cette recherche
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT